alexa Hepatic Dysfunction in Patients Infected with Human Imm

Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Hepatic Dysfunction in Patients Infected with Human Immune Deficiency Virus

To read the full article Peer-reviewed Article PDF image


To determine the incidence of hepatotoxicity in HIV sero positive and to investigate whether antiretroviral drugs could predispose HIV sero positive patients on antiretroviral drugs to hepatotoxicity.HIV patients were on antiretroviral drugs (triviro-LNS-Lamivudine, Nevirapine and Starvudine) 1-2 pills daily depending on the CD4 count. Moreso, have been on the drug for the duration of 2- 3 years. Blood samples were collected for the determination of clinical chemistry parameters such as liver enzymes (Les)-Lactate Dehydrogenase (LDH), Aspartate and Alanine Transaminases (AST and ALT) and Albumin (ALB). Sixty subjects were randomly selected and placed in three groups comprising 20 HIV infected patients who are not receiving antiretroviral drugs and group two twenty receiving antiretroviral drugs. Another twenty healthy non infected patients made up group 3 and these groups served as control, the patients are within Aba metro. The patients’ blood was collected and the serum separated. It was subsequently used for the analysis. All analysis was based on colorimetric method.The results obtained were subjected to statistical analysis using one-way analysis of variance. The result of the study showed that those patients on antiretroviral drugs had remarkable increase in LDH and AST levels compared to those not on the antiretroviral drugs and HIV negative patients (control (U/L) LDH 184.00± 5.75 VS 546 ± 25.60. AST control (U/L) 24.7.± 4.6 VS 67.95 ± 10.5. P<0.05).


Recommended Journals

Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version